South Korea
· Delayed Price · Currency is KRW PeopleBio Statistics
Total Valuation
PeopleBio has a market cap or net worth of KRW 76.24 billion. The enterprise value is 77.80 billion.
| Market Cap | 76.24B |
| Enterprise Value | 77.80B |
Important Dates
The last earnings date was Thursday, September 19, 2024.
| Earnings Date | Sep 19, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PeopleBio has 21.03 million shares outstanding. The number of shares has increased by 33.80% in one year.
| Shares Outstanding | 21.03M |
| Shares Change (YoY) | +33.80% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 15.40% |
| Owned by Institutions (%) | n/a |
| Float | 16.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.20 |
| PB Ratio | 6.02 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.89 |
| EV / Sales | 17.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.88 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.39 |
| Quick Ratio | 0.89 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.15 |
| Interest Coverage | -13.42 |
Financial Efficiency
Return on equity (ROE) is -169.11% and return on invested capital (ROIC) is -51.77%.
| Return on Equity (ROE) | -169.11% |
| Return on Assets (ROA) | -31.55% |
| Return on Capital (ROIC) | -51.77% |
| Revenue Per Employee | 68.60M |
| Profits Per Employee | -203.21M |
| Employee Count | 65 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 1.28 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.37% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -39.37% |
| 50-Day Moving Average | 3,609.80 |
| 200-Day Moving Average | 3,287.83 |
| Relative Strength Index (RSI) | 54.46 |
| Average Volume (20 Days) | 222,858 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PeopleBio had revenue of KRW 4.46 billion and -13.21 billion in losses. Loss per share was -663.03.
| Revenue | 4.46B |
| Gross Profit | 1.42B |
| Operating Income | -13.08B |
| Pretax Income | -14.61B |
| Net Income | -13.21B |
| EBITDA | -11.42B |
| EBIT | -13.08B |
| Loss Per Share | -663.03 |
Balance Sheet
The company has 174.84 million in cash and 1.68 billion in debt, giving a net cash position of -1.50 billion or -71.41 per share.
| Cash & Cash Equivalents | 174.84M |
| Total Debt | 1.68B |
| Net Cash | -1.50B |
| Net Cash Per Share | -71.41 |
| Equity (Book Value) | 12.73B |
| Book Value Per Share | 602.23 |
| Working Capital | 5.71B |
Cash Flow
In the last 12 months, operating cash flow was -10.86 billion and capital expenditures -450.80 million, giving a free cash flow of -11.31 billion.
| Operating Cash Flow | -10.86B |
| Capital Expenditures | -450.80M |
| Free Cash Flow | -11.31B |
| FCF Per Share | -537.94 |
Margins
Gross margin is 31.92%, with operating and profit margins of -293.24% and -296.21%.
| Gross Margin | 31.92% |
| Operating Margin | -293.24% |
| Pretax Margin | -327.53% |
| Profit Margin | -296.21% |
| EBITDA Margin | -256.15% |
| EBIT Margin | -293.24% |
| FCF Margin | -253.72% |
Dividends & Yields
PeopleBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.80% |
| Shareholder Yield | -33.80% |
| Earnings Yield | -18.29% |
| FCF Yield | -14.84% |
Stock Splits
The last stock split was on October 23, 2023. It was a forward split with a ratio of 1.2.
| Last Split Date | Oct 23, 2023 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
PeopleBio has an Altman Z-Score of -1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1 |
| Piotroski F-Score | n/a |